Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$124.12
pos +0.23
+0.19%
Today's Range: 122.54 - 124.60 | CELG Avg Daily Volume: 5,250,000
Last Update: 01/26/15 - 4:00 PM EST
Volume: 3,789,772
YTD Performance: 10.75%
Open: $123.55
Previous Close: $123.89
52 Week Range: $66.85 - $124.38
Oustanding Shares: 798,704,188
Market Cap: 98,807,695,097
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 16 16 16
Moderate Buy 1 1 1 1
Hold 4 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.26 1.26 1.26
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 64.77
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
64.77 64.70 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
23.40% 47.01% 237.44%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.88 $1.10 $3.26 $5.05
Number of Analysts 2 1 2 1
High Estimate $0.88 $1.10 $3.26 $5.05
Low Estimate $0.88 $1.10 $3.26 $5.05
Prior Year $0.67 $0.73 $2.68 $3.26
Growth Rate (Year over Year) 32.33% 50.68% 21.64% 54.91%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jan 15, 2015 | 3:40 PM EST

Use the overall weakness to pick up the America First stocks.

By

James "Rev Shark" DePorre

 | Jan 13, 2015 | 4:22 PM EST

This market is a mess.

By

Jim Cramer

 | Jan 13, 2015 | 1:49 PM EST

And they're both named Bob.

By

Jim Cramer

 | Jan 13, 2015 | 11:59 AM EST

But tomorrow we hear from the banks.

updateJP Morgan Healthcare Conf.

Jan 12, 2015 | 6:45 AM EST

JPMorgan Healthcare Conference (Day 1 of 4) - 01/12/15 - 01/15/15 San Francisco, CA

By

Timothy Collins

 | Jan 8, 2015 | 10:09 AM EST
Do you need to pick one name?
By

Kate Stalter

 | Jan 6, 2015 | 12:00 PM EST

They are prone to being whipsawed by news.

By

Jim Cramer

 | Dec 23, 2014 | 2:36 PM EST

Here's the best way to play them.

By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 19, 2014 | 7:16 PM EST

There had been no catalysts.

Shares of Colgate-Palmolive are under pressure again today. On Friday CL dropped ove...
In a perfect intermediate-term set-up, I would like to see the Market Vectors Gold Miners ...
I suspect with the events of the past couple weeks we won't see much push toward a shift i...
Homegoods retailer Bed, Bath & Beyond (BBBY) was hit hard a couple of weeks ago, dropp...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.